特朗普与九家药企达成协议，大幅降低药价

Core Viewpoint - The agreement between President Trump and nine major pharmaceutical companies aims to significantly reduce drug prices for government Medicaid programs and cash-paying patients [1] Group 1: Agreement Details - The pharmaceutical companies involved include Bristol-Myers Squibb, Gilead Sciences, Merck, and Genentech, a subsidiary of Roche [1] - Other companies that have joined the agreement are Novartis, Amgen, Boehringer Ingelheim, Sanofi, and GlaxoSmithKline [1] - The agreement stipulates that pharmaceutical companies will lower prices for most drugs sold to low-income individuals under Medicaid and commit to achieving "substantial savings" on widely used medications [1]